Articles On Universal Biosensors Inc (ASX:UBI)

The Universal Biosensors, Inc. (ASX: UBI) share price is in negative territory today despite announcing a distribution deal. In early morning trade, the medical diagnostics company is swapping hands for 71 cents, down 2.7%. What did Univer...

After a few near misses, the ASX has punched through 7,000 percentage points for the first time since the COVID-19 market crash. The ASX 200 rose by 0.70 per cent to 7,025 points while the ASX Emerging Companies Index rose by 0.56 per cent...

The Universal Biosensors, Inc (ASX: UBI) share price is rising today, after good news from the company. It has entered into a distribution agreement with Chilean quality diagnostics, control and research company Singularity SpA. The agreem...

Source: Ratanapon Srisuneton, Shutterstock Summary Universal Biosensors has entered into exclusive agreements for the commercialisation and development of its biosensors. Avecho has received ethics approval to conduct an Australian Ph...

Universal Biosensors Inc (ASX: UBI) shares are soaring today after the company shared news of deals with Deakin and Swinburn. At the time of writing, the Universal Biosensors share price is trading 9.68% higher at 68 cents.  The deals will...

Small caps have gained for a sixth straight day, even as their larger peers declined. The Small Ordinaries index of Australia’s 101st to 300th biggest companies finished the week up 6.7 points, or 0.2 per cent, to a fresh 13-year high of 3,...

Closing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers. Data is taken at the market close – at 4.10pm AEDT. Stocks highlighted in yellow rose (or fell) after making announcements during intraday trade.   WINNERS Scr...

The Universal Biosensors, Inc. (ASX: UBI) share price is rocketing today, up 36%. The positive price movement after two company announcements: an agreement for cancer detection technology and an exclusive supply agreement. At the time of w...

Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

S&P 500 closes at yet another record high All major US indices rose overnight, with S&P 500 closing at a record high again, marking the 19th time it has done so this year. The index rose by 0.42%. Dow Jones index also rose by 0.17%,...

The Universal Biosensors, Inc (ASX: UBI) share price is rising today after the company signed a Canadian distribution agreement for its wine testing platform. At the time of writing, the Universal Biosensors share price is up 1.96% trading...

Summary Shares of Universal Biosensors (ASX:UBI) jumped more than 4 per cent in the early trade after a deal between its Canadian subsidiary, Hemostasis Reference Laboratory (HRL), and Bayer AG. The agreement between the two entities i...

Universal Biosensors Inc. (ASX: UBI) shares are on the run today. This comes as the company’s Canadian subsidiary signed a new deal. The news has sent the Universal share price 4.5% higher to 46 cents. What’s driving the Universal share pr...

30 Dec 2020 - Universal Biosensors, Inc. (ASX:UBI) says its Canadian subsidiary, Hemostasis Reference Laboratory Inc (HRL), has entered into an agreement with Bayer AG of Germany f…

The Universal Biosensors, Inc. (ASX: UBI) share price is on the rise today after the company announced that it has signed a new deal with LifeScan. During mid-morning trade, shares in the medical diagnostics company reached an intraday hig...

The Universal Biosensors, Inc. (ASX: UBI) share price reached a multi-year high of 50 cents today. This comes as the company announced a new distribution agreement with Grapeworks Pty Ltd. Its high was short lived, however, with the Univer...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week With quart...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week The life s...

Neuren Pharmaceuticals (ASX: NEU) is getting interesting results from a mouse trial of a treatment for Phelan-McDermid syndrome (PMS), a rare genetic illness which exhibits symptoms of conditions including autism and epilepsy. The study fou...

Up and down diagnostics microcap Universal Biosensors (ASX:UBI) had an up quarter in December, with cash flow turning positive. The company was $3m in the black for the quarter, after being paid $6.4m in receipts. Of the last eight quarters...

Special Report: Wright says his skillset is ideally suited to add value as the company embarks on an exciting growth phase. For Hydrix (ASX:HYD), FY20 is shaping up as a defining year for the business as it looks to continue earnings moment...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Medibio (ASX: MEB) has gained 24 per cent this morning after announcing an integration partnership with digital corporate wellness solution WellteQ. Medibio’s “ilumen” digital mental well-being assessment will be integrated into WellteQ’s s...